Flohale 2mg Respules
$96.00 – $270.00Price range: $96.00 through $270.00
SKU : N/A
Category : Inhaler & Respules
Flohale 2 mg Respules, containing fluticasone propionate, is an inhaled corticosteroid used under medical supervision for the prevention and long‑term management of asthma and chronic airway inflammation.
Product Overview
Flohale 2mg Respules is a prescription respiratory medicine containing the active ingredient fluticasone propionate, classified as an inhaled corticosteroid. It is primarily indicated for the prevention and long‑term management of asthma and related chronic airway inflammatory conditions. This medicine is delivered via a nebuliser, which transforms the liquid formulation into a fine mist that patients inhale into their lungs for targeted action.
Asthma is a chronic condition characterised by inflammation and narrowing of the airways, leading to symptoms such as shortness of breath, wheezing, coughing, and chest tightness. By addressing the underlying inflammation, Flohale 2mg Respules helps reduce these symptoms when used regularly under medical supervision.
How It Works
The mechanism of action of fluticasone propionate involves reducing inflammation in the bronchial airways, which is central to conditions like asthma. Corticosteroids like fluticasone bind to glucocorticoid receptors in airway cells. This receptor‑steroid complex then enters the cell nucleus and influences gene expression, leading to suppression of pro‑inflammatory mediators such as cytokines and leukotrienes, and up‑regulation of anti‑inflammatory proteins. The result is reduced swelling, decreased mucus production, and improved airflow through the bronchioles.
Regular use of this medicine helps to control chronic airway inflammation and prevent asthma exacerbations. However, it is not a rescue medication and should not be used for immediate relief during an acute asthma attack. Acute symptoms require a fast‑acting bronchodilator as advised by a physician.
Uses / Indications
Flohale 2mg Respules is primarily used for:
-
Maintenance therapy of asthma to help prevent symptoms and reduce the frequency of asthma attacks.
-
Control of chronic inflammatory conditions of the lower respiratory tract such as chronic obstructive pulmonary disease (COPD), where inflammation contributes to airflow restriction and breathing difficulty.
By addressing the underlying inflammatory process, this therapy supports better respiratory function and can lead to improved quality of life for patients with persistent symptoms. However, its use in children under specific ages should be determined by a healthcare provider due to potential effects on growth and immune system function.
Composition
Each respule contains:
-
Active Ingredient: Fluticasone Propionate 2 mg per 2 ml liquid respule.
These respules are supplied as a sterile solution designed specifically for nebuliser use, facilitating direct delivery of medication to the lungs while minimising systemic exposure.
Administration
Flohale 2mg Respules is administered through a nebuliser machine, which converts the liquid medicine into a fine aerosol that patients inhale over several minutes. The typical procedure involves twisting off the respule cap, placing the contents into the nebuliser chamber, and inhaling slowly and deeply via mouthpiece or mask as instructed.
It is essential that patients follow dosage regimens and administration techniques exactly as prescribed by a physician, including cleaning the nebuliser device regularly to prevent contamination. Because this medication must be tailored to individual clinical conditions, dose adjustments and treatment duration should be overseen by a healthcare professional.
Storage Instructions
Store Flohale 2mg Respules at room temperature (typically below 30 °C), protected from direct sunlight and moisture. Keep all respules in their original packaging until use and out of reach of children and pets. Avoid freezing and do not use expired medicine.
Important Information / Warnings
-
Medical Supervision: Use only under the guidance of a qualified physician; this medicine is not suitable for self‑medication.
-
Not for Acute Attacks: This inhaled corticosteroid does not provide immediate relief in sudden asthma attacks. A rescue bronchodilator should be used in such cases, as advised by your clinician.
-
Immune Suppression: Long‑term corticosteroid use can suppress local immunity in the airways, increasing the risk of infections such as oral candidiasis. Rinsing the mouth after each administration may help reduce this risk.
-
Special Populations: Inform your doctor if you are pregnant, breastfeeding, or have other medical conditions such as tuberculosis or eye disorders.
For more detailed, peer‑reviewed information on asthma and long‑term corticosteroid therapy, you can visit MedlinePlus — Corticosteroids overview: https://medlineplus.gov/corticosteroids.html
| Pack Size |
30 Piece ,60 Piece ,90 Piece |
|---|
Related products
Asthalin Inhaler
Foracort Respules 0.5 mg
Foracort Rotacaps 100 mcg
Furamist Nasal Spray 27.5 mcg
Furamist Nasal Spray 27.5 mcg is a nasal spray formulation containing fluticasone furoate, provided in a metered-dose format for intranasal use. It should be used as directed by a healthcare professional.
Levolin Respules 0.31 mg
Levolin synchro breathe Inhaler
Levolin Synchro Breathe Inhaler, containing Levosalbutamol, is a physician-supervised bronchodilator indicated for asthma and COPD-related breathing conditions.
Seroflo 500 Inhaler
Seroflo 500 Inhaler is an inhalation product containing fluticasone propionate and salmeterol, available in inhaler form with a defined dosage strength. It is prepared and handled following standard quality and packaging practices.
This product is intended for use under the supervision of a qualified healthcare professional. Usage and administration may vary depending on individual requirements and regional guidelines.
Seroflo Ciphaler 500 mcg
Seroflo Ciphaler 500 mcg contains fluticasone propionate and salmeterol and is used under medical supervision for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

